Atlas Trials

Impact of CASP3 Gene in Chemoresistance

Clinical trial NCT06195371 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06195371
Sponsor
Gehad Salah El-Din shaker
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Breast Cancer
Start date
2024-05-01
Primary completion
2026-11-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.